Your browser doesn't support javascript.
loading
Development of liquiritigenin-phospholipid complex with the enhanced oral bioavailability / 中国天然药物
Article in En | WPRIM | ID: wpr-881037
Responsible library: WPRO
ABSTRACT
In the present study, liquiritigenin-phospholipid complex (LPC) was developed and evaluated to increase the oral bioavailability of liquiritigenin. A single-factor test methodology was applied to optimize the formulation and process for preparing LPC. The effects of solvent, drug concentration, reaction time, temperature and drug-to-phospholipid ratio on encapsulation efficiency were investigated. LPCs were characterized by UV-visible spectroscopy, differential scanning calorimetry (DSC), fourier transform infrared spectroscopy (FTIR), and powder X-ray diffractometry (PXRD). The apparent solubility and n-octanol/water partition coefficient were tested. The pharmacokinetic characteristics and bioavailability of the LPC were investigated after oral administration in rats in comparison with liquiritigenin alone. An LPC was successfully prepared. The optimum level of various parameters for liquiritigenin-phospholipid complex was obtained at the drug concentration of 8 mg·mL
Subject(s)
Key words
Full text: 1 Index: WPRIM Main subject: Phospholipids / Solvents / Biological Availability / Administration, Oral / Flavanones Limits: Animals Language: En Journal: Chinese Journal of Natural Medicines (English Ed.) Year: 2020 Type: Article
Full text: 1 Index: WPRIM Main subject: Phospholipids / Solvents / Biological Availability / Administration, Oral / Flavanones Limits: Animals Language: En Journal: Chinese Journal of Natural Medicines (English Ed.) Year: 2020 Type: Article